Scilight Press

Author Information

Received: 15 Sep 2024 | Revised: 23 Oct 2024 | Accepted: 23 Oct 2024 | Published: 09 Apr 2025

Abstract

Keywords

gut microbiota | fungi | metagenomics | metabolomics | immune regulation

References 

• 1.
  Almeida, A.; Mitchell, A.L.; Boland, M.; et al. A new genomic blueprint of the human gut microbiota. Nature 2019, 568, 499–504.
• 2.
  Leviatan, S.; Shoer, S.; Rothschild, D.; et al. An expanded reference map of the human gut microbiome reveals hundreds of previously unknown species. Nat. Commun. 2022, 13, 3863.
• 3.
  Yan, Q.; Li, S.; Yan, Q.; et al. A genomic compendium of cultivated human gut fungi characterizes the gut mycobiome and its relevance to common diseases. Cell 2024, 187, 2969–2989.
• 4.
  Garcia-Bonete, M.J.; Rajan, A.; Suriano, F.; et al. The underrated gut microbiota helminths, bacteriophages, fungi, and archaea. Life 2023, 13, 1765.
• 5.
  Fan, Y.; Pedersen, O. Gut microbiota in human metabolic health and disease. Nat. Rev. Microbiol. 2021, 19, 55–71.
• 6.
  Woźniak, D.; Cichy, W.; Przysławski, J.; et al. The role of microbiota and enteroendocrine cells in maintaining homeostasis in the human digestive tract. Adv. Med. Sci. 2021, 66, 284–292.
• 7.
  Chu, J.; Feng, S.; Guo, C.; et al. Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: A review. Biomed. Pharmacother. 2023, 164, 114985.
• 8.
  Colella, M.; Charitos, I.A.; Ballini, A.; et al. Microbiota revolution: How gut microbes regulate our lives. World J. Gastroenterol. 2023, 29, 4368.
• 9.
  Zhou Y.-D.; Liang F.-X.; Tian H.-R.; et al. Mechanisms of gut microbiota-immune-host interaction on glucose regulation in type 2 diabetes. Front. Microbiol. 2023, 14, 1121695.
• 10.
  Fujisaka, S.; Watanabe, Y.; Tobe, K. The gut microbiome: A core regulator of metabolism. J. Endocrinol. 2023, 256, e220111.
• 11.
  Kim, S.; Seo S.-U.; Kweon M.-N. Gut microbiota-derived metabolites tune host homeostasis fate. In Seminars in Immunopathology; Springer: Berlin/Heidelberg, Germany, 2024; p. 2.
• 12.
  Chen, L.; Zhang, L.; Hua, H.; et al. Interactions between toll-like receptors signaling pathway and gut microbiota in host homeostasis. Immun. Inflamm. Dis. 2024, 12, e1356.
• 13.
  Huseyin, C.E.; O’Toole, P.W.; Cotter, P.D.; et al. Forgotten fungi—The gut mycobiome in human health and disease. FEMS Microbiol. Rev. 2017, 41, 479–511.
• 14.
  Di Paola, M.; Rizzetto, L.; Stefanini, I.; et al. Comparative immunophenotyping of Saccharomyces cerevisiae and Candida spp. strains from Crohn’s disease patients and their interactions with the gut microbiome. J. Transl. Autoimmun. 2020, 3, 100036.
• 15.
  Peroumal, D.; Sahu, S.R.; Kumari, P.; et al. Commensal fungus Candida albicans maintains a long-term mutualistic relationship with the host to modulate gut microbiota and metabolism. Microbiol. Spectr. 2022, 10, e02462-22.
• 16.
  Wang, X.; Wu, S.; Li, L.; et al. Candida albicans overgrowth disrupts the gut microbiota in mice bearing oral cancer. Mycology 2024, 15, 57–69.
• 17.
  Pérez, J.C. Fungi of the human gut microbiota: Roles and significance. Int. J. Med. Microbiol. 2021, 311, 151490.
• 18.
  Richard, M.L.; Sokol, H. The gut mycobiota: Insights into analysis, environmental interactions and role in gastrointestinal diseases. Nat. Rev. Gastroenterol. Hepatol. 2019, 16, 331–345.
• 19.
  Zhai, B.; Liao, C.; Jaggavarapu, S.; et al. Antifungal heteroresistance causes prophylaxis failure and facilitates breakthrough Candida parapsilosis infections. Nat. Med. 2024, 30, 3163–3172.
• 20.
  Bayoumy, A.B.; Mulder, C.J.J.; Mol, J.J.; et al. Gut fermentation syndrome: A systematic review of case reports. United Eur. Gastroenterol. J. 2021, 9, 332–342.
• 21.
  Demir, M.; Lang, S.; Hartmann, P.; et al. The fecal mycobiome in non-alcoholic fatty liver disease. J. Hepatol. 2022, 76, 788–799.
• 22.
  Hallen-Adams, H.E.; Suhr M.J. Fungi in the healthy human gastrointestinal tract. Virulence 2017, 8, 352–358.
• 23.
  Liu, T.; Asif, I.M.; Chen, Y.; et al. The Relationship between Diet, Gut Mycobiome, and Functional Gastrointestinal Disorders: Evidence, Doubts, and Prospects. Mol. Nutr. Food Res. 2024, 68, e2300382.
• 24.
  Kumamoto, C.A.; Gresnigt, M.S.; Hube, B. The gut, the bad and the harmless: Candida albicans as a commensal and opportunistic pathogen in the intestine. Curr. Opin. Microbiol. 2020, 56, 7–15.
• 25.
  d’Enfert, C.; Kaune, A.K.; Alaban, L.R.; et al. The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: Current knowledge and new perspectives. FEMS Microbiol. Rev. 2021, 45, fuaa060.
• 26.
  Boutin, R.C.T.; Sbihi, H.; McLaughlin, R.J.; et al. Composition and Associations of the Infant Gut Fungal Microbiota with Environmental Factors and Childhood Allergic Outcomes. mBio 2021, 12, e0339620.
• 27.
  Maas, E.; Penders, J. Fungal-Bacterial Interactions in the Human Gut of Healthy Individuals. J. Fungi 2023, 9, 139.
• 28.
  Termén, S.; Tollin, M.; Rodriguez, E.; et al. PU.1 and bacterial metabolites regulate the human gene CAMP encoding antimicrobial peptide LL-37 in colon epithelial cells. Mol. Immunol. 2008, 45, 3947–3955.
• 29.
  Islam, K.B.; Fukiya, S.; Hagio, M.; et al. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology 2011, 141, 1773–1781.
• 30.
  Tang, W.H.W.; Li, D.Y.; Hazen S.L. Dietary metabolism, the gut microbiome, and heart failure. Nat. Rev. Cardiol. 2019, 16, 137–154.
• 31.
  Qu, R.; Zhang, Y.; Ma, Y.; et al. Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer. Adv. Sci. 2023, 10, e2205563.
• 32.
  Chen, J.; Vitetta, L. Intestinal dysbiosis in celiac disease: Decreased butyrate production may facilitate the onset of the disease. Proc. Natl. Acad. Sci. USA 2021, 118, e2113655118.
• 33.
  Waclawiková B.; Codutti, A.; Alim, K.; et al. Gut microbiota-motility interregulation: Insights from in vivo, ex vivo and in silico studies. Gut Microbes 2022, 14, 1997296.
• 34.
  Wang, J.; Zhu, N.; Su, X.; et al. Gut-Microbiota-Derived Metabolites Maintain Gut and Systemic Immune Homeostasis. Cells 2023, 12, 793.
• 35.
  Gao, B.; Chi, L.; Zhu, Y. An Introduction to Next Generation Sequencing Bioinformatic Analysis in Gut Microbiome Studies. Biomolecules 2021, 11, 530.
• 36.
  Li, X.V.; Leonardi, I. Immune regulation by fungal strain diversity in inflammatory bowel disease. Nature 2022, 603, 672–678. Erratum in Nature 2022, 608, E21.
• 37.
  Gasch, A.P.; Yu, F.B.; Hose, J.; et al. Single-cell RNA sequencing reveals intrinsic and extrinsic regulatory heterogeneity in yeast responding to stress. PLoS Biol. 2017, 15, e2004050.
• 38.
  Nadal-Ribelles, M.; Islam, S.; Wei, W. Sensitive high-throughput single-cell RNA-seq reveals within-clonal transcript correlations in yeast populations. Nat. Microbiol. 2019, 4, 683–692.
• 39.
  Saint, M.; Bertaux, F. Single-cell imaging and RNA sequencing reveal patterns of gene expression heterogeneity during fission yeast growth and adaptation. Nat. Microbiol. 2019, 4, 480–491.
• 40.
  Chetty, A.; Blekhman, R. Multi-omic approaches for host-microbiome data integration. Gut Microbes. 2024, 16, 2297860.
• 41.
  Ost, K.S.; Round J.L. Commensal fungi in intestinal health and disease. Nat. Rev. Gastroenterol. Hepatol. 2023, 20, 723–734.